Kyriacos Mitrophanos

Title: Kyriacos Mitrophanos: Innovator in Retroviral Vector Technology

Introduction

Kyriacos Mitrophanos is a notable inventor based in Oxon, GB. He has made significant contributions to the field of biotechnology, particularly in the development of retroviral vectors. With a total of 2 patents, his work has advanced the understanding and application of genetic engineering.

Latest Patents

Mitrophanos's latest patents focus on retroviral vectors that comprise a functional splice donor site and a functional splice acceptor site. These vectors are designed to flank a first nucleotide sequence of interest (NOI). The functional splice donor site is positioned upstream of the functional splice acceptor site, and the retroviral vector is derived from a retroviral pro-vector. This innovative approach allows for the effective reverse transcription of the retroviral pro-vector, enhancing the potential for gene therapy applications.

Career Highlights

Throughout his career, Mitrophanos has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Oxford Biomedica Limited and Oxford Biomedica, Inc. His expertise in retroviral vector technology has positioned him as a key figure in the field.

Collaborations

Mitrophanos has collaborated with esteemed colleagues, including Christopher Robert Bebbington and Susan Mary Kingsman. These partnerships have contributed to the advancement of research and development in genetic engineering.

Conclusion

Kyriacos Mitrophanos is a distinguished inventor whose work in retroviral vector technology has made a significant impact in biotechnology. His patents and collaborations reflect his commitment to advancing genetic engineering and its applications.